PCYC - Pharmacyclics Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - - PCYC (949699)
General
Tickers
Insider
Date
Filing Date
  
Trade Date
  
Transaction Code
P - Purchase
S - Sale
A - Grant
D - Sale to Issuer
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Traded K$
Own Chg %
Share Price $
Liquidity M$
Filing Delay
Sort by
Max Results
N Days Ago
Multiple Days
No deriv clear
100 results for PCYC - Yahoo - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P52+2+4+13-22
S9-1+3+11+14

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

AD
2015-03-11
PCYCZanganeh MakyCOOS - Sale+OE$254.12-30,000443,019-6%-$7,623,444
DM
2015-03-11
PCYCSoni Manmeet SinghCFOS - Sale+OE$254.24-27,51454,611-34%-$6,995,262
D
2015-03-11
PCYCZanganeh MakyCOOS - Sale+OE$254.12-30,000443,019-6%-$7,623,444
D
2015-03-12
PCYCTan HeowChief Quality, Tech OperationsS - Sale+OE$254.51-1,0004,070-20%-$254,506
D
2014-11-13
PCYCFardis MariaChief of Oncology Ops, AllianS - Sale+OE$141.30-3,0003,193-48%-$423,902
D
2014-11-13
PCYCSoni Manmeet SinghCFOS - Sale+OE$141.44-1,00038,611-3%-$141,442
DM
2014-11-07
PCYCZanganeh MakyCOOS - Sale+OE$134.69-30,482287,300-10%-$4,105,643
D
2014-11-10
PCYCLove Richard BGCS - Sale+OE$133.87-1,500205-88%-$200,805
D
2014-11-07
PCYCFardis MariaChief of Oncology Ops, AllianS - Sale+OE$134.50-5,0003,193-61%-$672,500
DM
2014-09-03
PCYCZanganeh MakyCOOS - Sale+OE$121.75-12,000287,299-4%-$1,460,980
D
2014-08-27
PCYCLove Richard BGCS - Sale+OE$124.00-1,500204-88%-$186,000
D
2014-08-13
PCYCFardis MariaChief of Oncology Ops, AllianS - Sale+OE$121.01-4,0003,192-56%-$484,040
D
2014-08-13
PCYCTan HeowChief Quality, Tech OperationsS - Sale+OE$123.58-10,0001,873-84%-$1,235,808
D
2014-08-07
PCYCMcGreivy JesseChief Medical OfficerS - Sale+OE$120.92-34,0620-100%-$4,118,610
D
2014-03-04
PCYCHalvorson Eric HDirS - Sale+OE$138.33-3,4721,000-78%-$480,282
D
2014-03-04
PCYCChang Betty YVP, Research, BiologyS - Sale+OE$137.97-17,5003,754-82%-$2,414,4840000
M
2014-02-25
PCYCVan Den Broek RichardDirS - Sale$146.63-78,83529,610-73%-$11,559,6560000
D
2013-12-19
PCYCTan HeowChief Quality, Tech OperationsS - Sale+OE$100.87-5,000169-97%-$504,352
DM
2013-12-17
PCYCHemmi GregoryVP Chemical OperationsS - Sale+OE$100.52-20,00025,004-44%-$2,010,380
2013-12-16
PCYCZanganeh MakyCOOS - Sale$107.55-20,000287,095-7%-$2,151,000
DM
2013-12-13
PCYCErdtmann Rainer MSVP, IR, AdminS - Sale+OE$107.77-54,0005,497-91%-$5,819,795
D
2013-06-06
PCYCShearer Scott TVP, Global QualityS - Sale+OE$85.17-18,75018,750-50%-$1,596,994
D
2013-05-31
PCYCHemmi GregoryVP Chemical OperationsS - Sale+OE$91.96-50,00098,472-34%-$4,598,115
D
2013-05-31
PCYCTan HeowChief of Technical OperationsS - Sale+OE$91.84-5,2370-100%-$480,961
D
2013-05-31
PCYCLove Richard BVP, GCS - Sale+OE$89.00-8,0000-100%-$712,000
D
2013-05-31
PCYCMcGreivy JesseVP, Clinical ScienceS - Sale+OE$91.13-14,4790-100%-$1,319,510
D
2013-02-11
PCYCBuggy Joseph JVP, ResearchS - Sale+OE$69.97-12,0006,701-64%-$839,666
D
2013-02-05
PCYCLoury David JChief Scientific OfficerS - Sale+OE$70.58-20,000325-98%-$1,411,510
2013-01-17
PCYCMcGreivy JesseVP, Clinical ScienceS - Sale$67.29-5830-100%-$39,229
D
2013-01-11
PCYCHemmi GregoryVP Chemical OperationsS - Sale+OE$67.11-5,00022,992-18%-$335,550
D
2013-01-09
PCYCLoury David JChief Scientific OfficerS - Sale+OE$35.23-21,062325-98%-$742,014
2013-01-08
PCYCFardis MariaEVP, Operations, AlliancesS - Sale$65.00-2,500976-72%-$162,500
D
2013-01-08
PCYCLoury David JChief Scientific OfficerS - Sale+OE$64.70-10,000325-97%-$647,000
D
2013-01-07
PCYCFardis MariaEVP, Operations, AlliancesS - Sale+OE$64.20-3,5003,476-50%-$224,700
2012-12-31
PCYCVan Den Broek RichardDirS - Sale$58.50-7,171108,445-6%-$419,476
M
2012-12-27
PCYCVan Den Broek RichardDirS - Sale$57.99-30,285108,445-22%-$1,756,364
DM
2012-12-26
PCYCHemmi GregoryVP Chemical OperationsS - Sale+OE$59.20-13,00022,992-36%-$769,625
D
2012-12-20
PCYCLoury David JChief Scientific OfficerS - Sale+OE$61.12-39,469325-99%-$2,412,274
DM
2012-12-17
PCYCErdtmann Rainer MVP, IR Education TrainingS - Sale+OE$62.57-94,00027,485-77%-$5,881,790
D
2012-12-17
PCYCBuggy Joseph JVP, ResearchS - Sale+OE$62.14-50,0006,701-88%-$3,106,840
D
2012-05-17
PCYCMehta MineshDirS - Sale+OE$30.00-18,5650-100%-$556,950
D
2012-02-13
PCYCMehta MineshDirS - Sale+OE$25.00-11,9710-100%-$299,275+2+2
2012-02-10
PCYCBaker Biotech Capital (Gp), LLC10%P - Purchase$20.85+150,000557,211+37%+$3,128,040-4+1
D
2012-02-03
PCYCMehta MineshDirS - Sale+OE$20.00-11,9700-100%-$239,400-3+35+35
M
2012-01-24
PCYCBaker Biotech Capital (Gp), LLC10%P - Purchase$18.09+85,993407,211+27%+$1,555,487+3+3+35
M
2012-01-24
PCYCBaker Brothers Life Sciences Capital (Gp), LLC10%P - Purchase$18.09+500,6528,574,445+6%+$9,056,056+3+3+35
M
2012-01-24
PCYC14159 Capital (Gp), LLC10%P - Purchase$18.09+12,945195,858+7%+$234,156+3+3+35
DM
2012-01-19
PCYC14159 Capital (Gp), LLC10%P - Purchase$16.55+11,747182,913+7%+$194,458+7+10+51
DM
2012-01-19
PCYCBaker Brothers Life Sciences Capital (Gp), LLC10%P - Purchase$16.55+445,2388,073,793+6%+$7,370,448+7+10+51
DM
2012-01-19
PCYCBaker Biotech Capital (Gp), LLC10%P - Purchase$16.55+77,425321,218+32%+$1,281,751+7+10+51
D
2011-12-30
PCYCHemmi GregoryVP Chemical OperationsS - Sale+OE$14.91-18,12519,976-48%-$270,31000+25
2011-12-02
PCYCBaker Biotech Capital (Gp), LLC10%P - Purchase$15.42+14,561239,393+6%+$224,467-1-16-1
2011-12-02
PCYCBaker Brothers Life Sciences Capital (Gp), LLC10%P - Purchase$15.42+88,1977,603,655+1%+$1,359,615-1-16-1
2011-12-02
PCYC14159 Capital (Gp), LLC10%P - Purchase$15.42+2,360170,466+1%+$36,381-1-16-1
M
2011-11-28
PCYC14159 Capital (Gp), LLC10%P - Purchase$13.77+8,435168,106+5%+$116,188-2-1-1
M
2011-11-28
PCYCBaker Biotech Capital (Gp), LLC10%P - Purchase$13.97+64,799224,832+40%+$905,390-2-1-1
M
2011-11-28
PCYCBaker Brothers Life Sciences Capital (Gp), LLC10%P - Purchase$13.97+377,2807,515,458+5%+$5,271,464-2-1-1
M
2011-11-21
PCYC14159 Capital (Gp), LLC10%P - Purchase$12.50+7,017159,671+5%+$87,698-1+19+14
M
2011-11-21
PCYCBaker Brothers Life Sciences Capital (Gp), LLC10%P - Purchase$12.57+242,4987,138,178+4%+$3,047,620-1+19+14
M
2011-11-21
PCYCBaker Biotech Capital (Gp), LLC10%P - Purchase$12.63+7,351160,033+5%+$92,876-1+19+14
M
2011-09-30
PCYCBaker Biotech Capital (Gp), LLC10%P - Purchase$11.64+111,163152,682+268%+$1,293,933+4+11+12
2011-10-03
PCYCBaker Brothers Life Sciences Capital (Gp), LLC10%P - Purchase$11.59+81,8906,895,680+1%+$949,454+4+11+12
2011-10-03
PCYC14159 Capital (Gp), LLC10%P - Purchase$11.59+3,110152,654+2%+$36,058+4+11+12
2011-08-22
PCYC14159 Capital (Gp), LLC10%P - Purchase$9.96+4,426149,544+3%+$44,085+3+10+12+136
2011-08-22
PCYCBaker Brothers Life Sciences Capital (Gp), LLC10%P - Purchase$9.96+287,2646,813,790+4%+$2,861,270+3+10+12+136
2011-08-22
PCYCBaker Biotech Capital (Gp), LLC10%P - Purchase$9.96+39,71041,519>999%+$395,528+3+10+12+136
2011-06-21
PCYCDuggan Robert WCOB, CEO, 10%P - Purchase$8.85+678,00014,016,492+5%+$6,000,300+6+4+28+57
D
2010-10-05
PCYCHamdy Ahmed MdChief Medical OfficerS - Sale+OE$8.20-15,0002,010-88%-$123,000-4-6-22-23
D
2010-10-01
PCYCBuggy Joseph JVP, ResearchS - Sale+OE$8.01-46,6306,000-89%-$373,6690-5-24-29
2010-06-21
PCYCDuggan Robert WCOB, CEO, 10%P - Purchase$6.51+1,075,26813,417,092+9%+$6,999,995+10+9-7
DM
2010-01-19
PCYCBamdad CynthiaDirS - Sale+OE$4.19-11,5500-100%-$48,4040+3+45+70
D
2010-01-14
PCYCBamdad CynthiaDirS - Sale+OE$4.16-76,3290-100%-$317,8870-5+32+66
D
2008-10-01
PCYCRice Glenn CDirP - Purchase$2.03+40,50040,500New+$82,1660-3-36-41
2008-09-05
PCYCDuggan Robert WDir, 10%P - Purchase$2.47+176,0657,500,000+2%+$434,881-19-29-32-78
M
2008-08-21
PCYCDuggan Robert WDir, 10%P - Purchase$1.60+167,2427,323,935+2%+$267,587+7+18+31-44
M
2008-06-24
PCYCDuggan Robert WDir, 10%P - Purchase$1.82+54,4007,156,693+1%+$99,107-4-8-16-52
2008-06-23
PCYCDuggan Robert WDir, 10%P - Purchase$1.70+82,0187,102,293+1%+$139,431+60-7-45
A
2008-05-30
PCYCDuggan Robert WDir, 10%P - Purchase$1.05+1,909,6766,253,825+44%+$2,005,160+49+25+56-18
2008-05-30
PCYCDuggan Robert WDir, 10%P - Purchase$1.05+1,982,6816,326,830+46%+$2,081,815+1+60+70-5
M
2007-09-05
PCYCDuggan Robert W10%P - Purchase$2.58+28,2114,465,149+1%+$72,781+40-7-58
2007-08-22
PCYCMiller Richard A MdPres, CEO, DirP - Purchase$2.00+5,000326,798+2%+$10,000+1+1+21-39
2007-08-21
PCYCMiller Richard A MdPres, CEO, DirP - Purchase$2.00+5,000321,798+2%+$10,008+1+1+21-39
2007-08-22
PCYCLea LeivVP Fin, Admin, CFOP - Purchase$2.01+3,00018,893+19%+$6,030+1+1+21-39
2007-08-21
PCYCLea LeivVP Fin, Admin, CFOP - Purchase$2.02+2,00015,893+14%+$4,040+1+1+21-39
2007-08-21
PCYCInouye Michael KSVP, Corp, Comm Dev.P - Purchase$2.04+20,00020,000New+$40,754+1+1+21-39
2007-08-14
PCYCDuggan Robert W10%P - Purchase$2.18+22,0004,436,9380%+$47,949-2-4+20-46
2007-02-21
PCYCDuggan Robert W10%P - Purchase$3.06+310,3814,414,938+8%+$948,291+3-2-10-35
2007-02-21
PCYCDuggan Robert W10%P - Purchase$2.80+654,6193,657,575+22%+$1,831,467+3-2-10-35
2007-01-03
PCYCDuggan Robert W10%P - Purchase$4.89+108,3393,449,938+3%+$529,276+1+20-46
2006-12-29
PCYCDuggan Robert W10%P - Purchase$4.91+31,6613,341,599+1%+$155,560-5-3-5-48
2006-11-08
PCYCDuggan Robert W10%P - Purchase$4.75+405,0006,152,894+7%+$1,925,250+11+9+3-46
2006-11-08
PCYCGilburne Miles RDirP - Purchase$4.79+50,000140,000+56%+$239,445+4+16+11-41
2006-09-20
PCYCDuggan Robert W10%P - Purchase$4.90+23,5292,904,938+1%+$115,208+1+5+16-43
2006-09-19
PCYCDuggan Robert W10%P - Purchase$4.76+19,2162,881,409+1%+$91,540+1+5+16-43
2006-09-18
PCYCDuggan Robert W10%P - Purchase$4.75+17,7422,862,193+1%+$84,275+2+8+21-42
2006-09-08
PCYCDuggan Robert W10%P - Purchase$4.80+4,1122,844,4510%+$19,738+1-2+9-46
2006-09-07
PCYCDuggan Robert W10%P - Purchase$4.56+19,0362,840,339+1%+$86,7740-3+3-43
2006-09-06
PCYCDuggan Robert W10%P - Purchase$4.54+3,9992,821,3030%+$18,166+3+1+4-42
2006-09-05
PCYCDuggan Robert W10%P - Purchase$4.46+36,6962,817,304+1%+$163,713+3+4+2-42
2006-09-01
PCYCDuggan Robert W10%P - Purchase$4.48+20,1002,780,608+1%+$90,006+4+7+6-39
A Amended filing (a previous filing had an error)
D Derivative transaction exists (usually option exercise)
E Error filing (OpenInsider detected an error in the filing)
M Multiple insider transactions summarized; earliest reported transaction date and weighted average transaction price
Open: Yahoo - Finviz - Stockcharts - Google

Return to top
S - SaleSale of securities on an exchange or to another person
S - Sale on exerciseSale of securities on an exchange or to another person (after option exercise)
F - OptEx/tax paymentPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person